Bruce Bernstein is Director of Petros Pharmaceuticals, Inc.. Currently has a direct ownership of 308,346 shares of PTPI, which is worth approximately $30,834. The most recent transaction as insider was on Feb 19, 2025, when has been sold 300,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 308K
3594.54% 3M change
3594.54% 12M change
Total Value Held $30,834

Bruce Bernstein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 19 2025
BUY
Grant, award, or other acquisition
-
300,000 Added 49.31%
308,346 Common Stock
Apr 26 2023
BUY
Exercise of conversion of derivative security
-
6,050 Added 42.03%
8,346 Common Stock
Jan 20 2023
BUY
Exercise of conversion of derivative security
-
2,264 Added 49.65%
2,296 Common Stock

Also insider at

XSPA
XpresSpa Group, Inc. Consumer Cyclical
SNPX
Synaptogenix, Inc. Healthcare
WRAP
WRAP TECHNOLOGIES, INC. Technology
BB

Bruce Bernstein

Director
New York, NY

Track Institutional and Insider Activities on PTPI

Follow Petros Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTPI shares.

Notify only if

Insider Trading

Get notified when an Petros Pharmaceuticals, Inc. insider buys or sells PTPI shares.

Notify only if

News

Receive news related to Petros Pharmaceuticals, Inc.

Track Activities on PTPI